We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YTL:MYXYTL Corp Bhd. Analysis

Data as of 2026-03-15 - not real-time

$0.53

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

YTL Corp is trading near a technical support level while key momentum indicators suggest a potential rebound. The RSI is in oversold territory, offering a contrarian upside bias. A bullish MACD crossover reinforces the short‑term upside case. Recent quarterly earnings showed a notable improvement in profit, driven by stronger segment contributions. The dividend yield remains attractive and the payout ratio is comfortably low, supporting cash‑flow sustainability. Valuation metrics indicate the market price is well below intrinsic estimates, pointing to a sizable margin of safety. However, the balance sheet is heavily leveraged, with debt levels far exceeding equity. Volatility over the past month has been elevated, reflecting price swings despite the low beta. Liquidity appears thin, as trading volumes are modest relative to market cap. Overall, the stock presents a blend of upside catalysts and structural risks that merit a nuanced positioning.
Investors should weigh the attractive dividend and undervalued pricing against the debt load and sector‑specific regulatory environment before deciding on exposure.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • oversold RSI indicating potential bounce
  • bullish MACD crossover
  • attractive dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • significant undervaluation relative to intrinsic value
  • improving earnings momentum
  • stable cash‑flow support for dividend

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • high debt‑to‑equity ratio limiting financial flexibility
  • defensive utilities sector offering stability
  • consistent dividend payout reinforcing shareholder returns

Key Metrics & Analysis

Financial Health

Revenue Growth-5.90%
Profit Margin6.04%
P/E Ratio13.3
ROE13.24%
ROA4.18%
Debt/Equity201.11
P/B Ratio1.4
Op. Cash Flow$6.1B
Free Cash Flow$-2385762304
Industry P/E23.3

Technical Analysis

TrendNeutral
RSI0.2
Support$0.53
Resistance$0.60
MA 20$0.53
MA 50$0.56
MA 200$0.54
MACDBullish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair Value$1.87
GradeUndervalued
TypeValue
Dividend Yield2.23%

Risk Assessment

Beta0.03
Volatility35.94%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.